{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:11:48Z","timestamp":1790154708614,"version":"4.0.1"},"reference-count":149,"publisher":"FapUNIFESP (SciELO)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1590\/abd1806-4841.20152890","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T20:57:41Z","timestamp":1423083461000},"page":"62-73","source":"Crossref","is-referenced-by-count":205,"title":["Localized scleroderma: clinical spectrum and therapeutic update"],"prefix":"10.1590","volume":"90","author":[{"given":"Mariana Figueiroa","family":"Careta","sequence":"first","affiliation":[{"name":"University of S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Romiti","sequence":"additional","affiliation":[{"name":"University of S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","series-title":"Dermatology in General Medicine","first-page":"1841","author":"Fitzpatrick TB","year":"1987"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1365-2133.1997.tb01573.x","article-title":"Computed tomography reveals thickened subcutaneous tissue in scleroderma","volume":"137","author":"Matsuura K","year":"1997","journal-title":"Br J Dermatol"},{"key":"ref3","series-title":"Textbook of pediatric rheumatology","first-page":"505","volume-title":"The systemic scleroderma and related disorders","author":"Cassidy JT","year":"2001"},{"key":"ref4","series-title":"Textbook of pediatric rheumatology","first-page":"535","volume-title":"Localized slerodermas","author":"Nelson A","year":"2001"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0031-3955(16)40058-1","article-title":"Scleroderma in children","volume":"42","author":"Uziel Y","year":"1995","journal-title":"Pediatr Clin North Am"},{"key":"ref6","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmstead Country 1960-1993","volume":"24","author":"Peterson LS","year":"1997","journal-title":"J Rheumatol"},{"key":"ref7","first-page":"171","article-title":"Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases","volume":"13","author":"Marzano AV","year":"2003","journal-title":"Eur J Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children","volume":"45","author":"Zulian F","year":"2006","journal-title":"An international study. Rheumatology (Oxford)"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimune syndromes in morphea: a review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger JJ","year":"2009","journal-title":"Arch Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett N","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech S","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00005792-199409000-00002","article-title":"Internal involvement in localized scleroderma","volume":"73","author":"Dehen L","year":"1994","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/art.1780360318","article-title":"Localized scleroderma progressing to systemic disease: case report and review of the literature","volume":"36","author":"Birdi N","year":"1993","journal-title":"Arthritis Rheum"},{"key":"ref14","first-page":"1955","article-title":"Progression of childhood linear scleroderma to fatal systemic sclerosis","volume":"21","author":"Mayorquin FJ","year":"1994","journal-title":"J Rheumatol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of Morphea (Localized Scleroderma)","volume":"70","author":"Peterson LS","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"ref16","first-page":"318","article-title":"Localized scleroderma including morphea, linear scleroderma, and eosinophilic fasciitis","volume":"26","author":"Nelson A","year":"1996","journal-title":"Curr Probl Pediatr"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized Scleroderma in Childhood is not just a skin disease","volume":"52","author":"Zulian F","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00000372-199408000-00011","article-title":"Bullous morphea: a distinct entity","volume":"16","author":"Trattner A","year":"1994","journal-title":"Am J Dermatopathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1525-1470.1991.tb00936.x","article-title":"Solitary morphea profunda in a 5-year-old girl: case report and review of the literature","volume":"8","author":"Kobayashi KA","year":"1991","journal-title":"Pediatr Dermatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2133.1993.tb00156.x","article-title":"Solitary fibrosing paraspinal plaque: solitary morphea profunda","volume":"128","author":"Kirsner RS","year":"1993","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2230.2004.01422.x","article-title":"Does solitary morphea profunda progress?","volume":"29","author":"Azad J","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000018321","article-title":"Primary atrophic profound linear scleroderma","volume":"200","author":"Blaszczyk M","year":"2000","journal-title":"Dermatology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<890::AID-MUS16>3.0.CO;2-W","article-title":"Selective ipsilateral neuromuscular involvement in a case of facial and somatic hemiatrophy","volume":"20","author":"Malandrini A","year":"1997","journal-title":"Muscle Nerve"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-4615-4857-7_14","article-title":"Linear scleroderma en coup de sabre. Relationship with progressive facial hemiatrophy (PFH)","volume":"455","author":"Blaszczyk M","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1525-1470.2006.00289.x","article-title":"Deep morphea after vaccination in two young children","volume":"23","author":"Torrelo A","year":"2006","journal-title":"Pediatr Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1365-4362.1995.tb01569.x","article-title":"Morphea-like reaction from vitamin K1","volume":"34","author":"Morell A","year":"1995","journal-title":"Int J Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0190-9622(94)70113-X","article-title":"Bullous morphea: clinical pathologic and immunopathologic evaluation of 13 cases","volume":"30","author":"Daoud MS","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"ref28","first-page":"251","article-title":"Morphea profunda. A new concept and a histopathologic study of 23 cases","volume":"3","author":"Su WPD","year":"1981","journal-title":"Am J Dermatopathol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1046\/j.1365-2230.2002.10493.x","article-title":"Concurrent development of dermatomyositis and morphea profunda","volume":"27","author":"Park JH","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"ref30","first-page":"171","article-title":"Generalized morphea: systemic aspects of a cutaneous disease. Description of 12 cases and review of the literature","volume":"85","author":"Bielsa I","year":"1985","journal-title":"Med Clin (Barc)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1440-0960.1992.tb00107.x","article-title":"Linear scleroderma with severe leg deformity","volume":"33","author":"Hatzis JA","year":"1992","journal-title":"Australas J Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1085-5629(98)80059-X","article-title":"Localized scleroderma","volume":"17","author":"Tuffanelli DL","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archderm.1987.01660270088021","article-title":"Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea","volume":"123","author":"Falanga V","year":"1987","journal-title":"Arch Dermatol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1468-3083.2005.00979.x","article-title":"Long-lasting follow-up favours a close relationship between progressive facial hemiatrophy and scleroderma en coup de sabre","volume":"19","author":"Jablonska S","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1468-3083.2002.00442.x","article-title":"Scleroderma \"en coup de sabre\" and progressive facial hemiatrophy. Is it possible to differentiate them?","volume":"16","author":"Orozco-Covarrubias L","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref36","first-page":"1997","article-title":"Progressive facial hemiatrophy: central nervous system involvement and relationship with scleroderma en coup de sabre","volume":"30","author":"Blaszczyk M","year":"2003","journal-title":"J Rheumatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients","volume":"56","author":"Tollefson MM","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3899\/jrheum.090708","article-title":"Treatment of pediatric localized scleroderma: results of a survey of North American pediatric rheumatologists","volume":"37","author":"Li SC","year":"2010","journal-title":"J Rheumatol"},{"key":"ref39","first-page":"101","article-title":"Medico-chirurgical transactions of 1854 quoted by Fox TC: note on the history of scleroderma in England","volume":"4","author":"Addison CH","year":"1892","journal-title":"Br J Dermatol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1875-9572(09)60081-4","article-title":"Linear scleroderma \"en coup de sabre\": initial presentation as intractable partial seizures in a child","volume":"50","author":"Chiang KL","year":"2009","journal-title":"Pediatr Neonatol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410370519","article-title":"Intracerebral involvement in scleroderma en coup de sabre: report of case with neuropathologic findings","volume":"37","author":"Chung MH","year":"1995","journal-title":"Ann Neurol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00315664","article-title":"Progressive inflammatory lesions of the brain parenchyma in localized scleroderma of the head","volume":"237","author":"Luer W","year":"1990","journal-title":"J Neurol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s001050050091","article-title":"Bilateral tempoparietal scleroderma \"en coup de sabre\"","volume":"45","author":"Ostertag JU","year":"1994","journal-title":"Hautarzt"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1525-1470.2000.01757.x","article-title":"Bilateral En Copu de Sabre - A Rare Entity","volume":"17","author":"Rai R","year":"2000","journal-title":"Pediatr Dermatol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-5945-1-9","article-title":"Billateral linear scleroderma \"en coup de sabre\" associated with facial atrophy and neurological complications","volume":"1","author":"Gambichler T","year":"2001","journal-title":"BMC Dermatol"},{"key":"ref46","series-title":"Collections from unpublished papers","first-page":"178","author":"Parry CH","year":"1825"},{"key":"ref47","first-page":"75","article-title":"Trophoneurosen","author":"Romberg MH","year":"1946","journal-title":"Klinische ergebnisse"},{"key":"ref48","first-page":"599","article-title":"Parry Romberg syndrome. Review and new observations based on a case with unusual features","volume":"47","author":"Jappe U","year":"1996","journal-title":"Hautarzt"},{"key":"ref49","first-page":"125","article-title":"Progressive facial hemiatrophy and scleroderma en coup de sabre: clinical presentation and course as related to the onset in early childhood and young adults","volume":"48","author":"Jablonska S","year":"1998","journal-title":"Arch Argent Dermatol"},{"key":"ref50","first-page":"844","article-title":"The Parry- Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlaping conditions?","volume":"19","author":"Lehmann TJA","year":"1992","journal-title":"J Rheumatol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1046\/j.1528-1157.2001.45800.x","article-title":"Neuropathological findings in a patient with epilepsy and the Parry-Romberg syndrome","volume":"42","author":"DeFelipe J","year":"2001","journal-title":"Epilepsia"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1212\/WNL.50.6.1915","article-title":"Progressive facial hemiatrophy: Abnormality of intracranial vasculature","volume":"50","author":"Woolfenden AR","year":"1998","journal-title":"Neurology"},{"key":"ref53","first-page":"751","article-title":"Clinical and radiologic findings in progressive facial hemiatrophy (Parry-Romberg syndrome)","volume":"18","author":"Cory RC","year":"1997","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1469-8749.1997.tb07469.x","article-title":"Progressive facial hemiatrophy: MRI appearances","volume":"39","author":"Taylor HM","year":"1997","journal-title":"Dev Med Child Neurol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0022-3476(05)80693-6","article-title":"Childhood linear scleroderma \"en coup de sabre\" with uveitis","volume":"117","author":"Goldenstein-Schainberg C","year":"1990","journal-title":"J Pediatr"},{"key":"ref56","first-page":"141","article-title":"Childhood scleroderma and its peculiarites","volume":"58","author":"Blaszczyk M","year":"1996","journal-title":"Cutis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1085-5629(99)80019-4","article-title":"Morphea and localized scleroderma in children","volume":"18","author":"Vierra E","year":"1999","journal-title":"Semin Cutan Med Surg"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archneurpsyc.1945.02300080003001","article-title":"Progressive facial hemiatrophy","volume":"54","author":"Wartenberg R","year":"1945","journal-title":"Arch Neurol Psychiatry"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jama.1927.02680390019007","article-title":"Trophic disorders of central origin: report of a case of progressive facial hemiatrophy associated with a lipodistrophy and other metabolic derangements","volume":"88","author":"Wolf HG","year":"1927","journal-title":"JAMA"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaad.2005.10.020","article-title":"Clinical and serological characteristics of progressive facial hemiatrophy: A case series of 12 patients","volume":"54","author":"Sommer A","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/bjo.2007.116038","article-title":"Ocular involvement in children with localised scleroderma: a multi-centre study","volume":"91","author":"Zannin ME","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1468-3083.2004.00862.x","article-title":"Parry-Romberg syndrome: a possible association with borreliosis","volume":"18","author":"Sahin MT","year":"2004","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1085-5629(98)80061-8","article-title":"Pediatric scleroderma","volume":"17","author":"Emery H","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0190-9622(08)80421-5","article-title":"Progressive facial hemiatrophy (Parry-Romberg syndrome) and antibodies to Borrelia","volume":"25","author":"Esgleyes-Ribot T","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick C","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The patogenesis of systemic sclerosis","volume":"6","author":"Katsumoto TR","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemics sclerosis (Scleroderma) in three United States cohorts","volume":"44","author":"Arnett FC","year":"2001","journal-title":"Arthritis Rheum"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archneur.1982.00510130046011","article-title":"Progressive hemifacial atrophy. Report of three cases, including one observed over 43 years and computed tomographic findings","volume":"39","author":"Asher SW","year":"1982","journal-title":"Arch Neurol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/jnnp.70.3.382","article-title":"Scleroderma \"en coup de sabre\": pathological evidence of intracerabral inflammation","volume":"70","author":"Stone J","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1525-1470.1997.tb00216.x","article-title":"Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea","volume":"14","author":"Menni S","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/01.WNL.0000124518.25087.18","article-title":"Neuroimaging findings in scleroderma en coup de sabre","volume":"62","author":"Appenzeller S","year":"2004","journal-title":"Neurology"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1542\/peds.2005-0470","article-title":"Linear cleroderma en coup de sabre with associated neurologic abnormalities","volume":"117","author":"Holland KE","year":"2006","journal-title":"Pediatrics"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/03009740600556126","article-title":"Linear scleroderma \"en coup de sabre\" associated with cerebral and ocular vasculitis","volume":"35","author":"Holl-Wieden A","year":"2006","journal-title":"Scand J Rheumatol"},{"key":"ref74","first-page":"956","article-title":"Intracranial findings in progressive facial atrophy","volume":"19","author":"Fry JA","year":"1992","journal-title":"J Rheumatol"},{"key":"ref75","first-page":"29","article-title":"Trauma-induced linear scleroderma","volume":"63","author":"Yamanaka CT","year":"1999","journal-title":"Cutis"},{"key":"ref76","first-page":"622","article-title":"Physical injury as a provoking fator in three patients with scleroderma","volume":"18","author":"Komocsi A","year":"2000","journal-title":"Clin Exp Rheumatol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ana.410390223","article-title":"Linear scleroderma and intractable epilepsy: neuropathologic evidence for a chronic inflamatory process","volume":"39","author":"Pupillo G","year":"1996","journal-title":"Ann Neurol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1212\/WNL.48.4.1013","article-title":"Progressive facial hemiatrophy and epilepsy","volume":"48","author":"Dupont S","year":"1997","journal-title":"Neurology"},{"key":"ref79","first-page":"145","article-title":"MR of brain involvement in progressive facial hemiatrophy (Romberg disease): Reconsideration of a syndrome","volume":"15","author":"Terstegge K","year":"1994","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref80","first-page":"119","article-title":"Congenital facial hemiatrophy. Report of two pediatric cases","volume":"201","author":"Nussgens Z","year":"1992","journal-title":"Klin Monbl Augenheilkd"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2133.2008.08647.x","article-title":"Linear morphea follows Blaschko's lines","volume":"159","author":"Weibel L","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0190-9622(98)70586-9","article-title":"Frontoparietal scleroderma \"en coup de sabre\" following Blaschko's lines","volume":"38","author":"Soma Y","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/s0387-7604(02)00147-x","article-title":"Linear scleroderma associated with progressive brain atrophy","volume":"25","author":"Grosso S","year":"2003","journal-title":"Brain Dev"},{"key":"ref84","first-page":"73","article-title":"Autoantibodies in Parry-Romberg syndrome: a serological study of 14 patients","volume":"22","author":"Garcia-de la Torre I","year":"1995","journal-title":"J Rheumatol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.61.5.674","article-title":"Parry-Romberg syndrome: a global survey of 205 patients using the internet","volume":"61","author":"Stone J","year":"2003","journal-title":"Neurology"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-510X(98)00267-6","article-title":"Localized scleroderma associated with progressing ischemic stroke","volume":"163","author":"Kanzato N","year":"1999","journal-title":"J Neurol Sci"},{"key":"ref87","first-page":"1135","article-title":"Linear scleroderma: a response to neurological injury? Report and literature review","volume":"16","author":"Littman B","year":"1989","journal-title":"J Rheumatol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s002340050525","article-title":"Parry Romberg syndrome: Follow up imaging during supressive therapy","volume":"39","author":"Goldberg-Stern H","year":"1997","journal-title":"Neuroradiology"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.74.5.661","article-title":"Linear scleroderma \"en coup de sabre\" coexisting with plaque-morphea: neuroradiological manifestation and response to corticosteroids","volume":"74","author":"Unterberger I","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref90","first-page":"65","article-title":"Localized cutaneous scleroderma","volume":"11","author":"Krafchik BR","year":"1992","journal-title":"Semin Dermatol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0738-081X(92)90087-F","article-title":"Clinical relevance of immunologic findings in scleroderma","volume":"10","author":"Jablonska S","year":"1992","journal-title":"Clin Dermatol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of Consensus Treatment Plans for Juvenile Localized Scleroderma: A Roadmap Toward Comparative Effectiveness Studies in Juvenile Localized Scleroderma","volume":"64","author":"Li SC","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000018236","article-title":"Double-lined frontparietal scleroderma en coup de sabre","volume":"199","author":"Itin PH","year":"1999","journal-title":"Dermatology"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0736-8046.2004.21109.x","article-title":"Subdural hygroma in a patient with Parry-Romberg syndrome","volume":"21","author":"Sandhu K","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02012193","article-title":"Localized scleroderma: Imaging fetures","volume":"24","author":"Liu P","year":"1994","journal-title":"Pediatr Radiol"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1212\/01.wnl.0000334474.88923.e3","article-title":"Neurologic manifestations of localized scleroderma. A case report and literature review","volume":"71","author":"Kister I","year":"2008","journal-title":"Neurology"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0733-8619(03)00057-4","article-title":"Neurologic manifestations of connective tissue disease","volume":"20","author":"Nadeau SE","year":"2002","journal-title":"Neurol Clin"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.autrev.2013.05.005","article-title":"Prospective study to evaluate the clinical and radiological outcome of patients with scleroderma of the face","volume":"12","author":"Careta1 MF","year":"2013","journal-title":"Autoimmun Rev"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/bjo.74.11.694","article-title":"Linear scleroderma associated with ptosis and motility disorders","volume":"74","author":"Suttorp-Schulten MS","year":"1990","journal-title":"Br J Ophthalmol"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1067\/S0190-9622(03)00901-0","article-title":"Scleroderma en coup de sabre with central nervous system and ophthalmologic involvement: treatment of ocular symptoms with interferon gamma","volume":"49","author":"Obermoser G","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archderm.1956.01550120049012","article-title":"Localized scleroderma: a clinical study of two hundred thirty-five cases","volume":"74","author":"Christianson HB","year":"1956","journal-title":"AMA Arch Derm"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","article-title":"An evaluation of long-term outcomes in adults with pediatric-onset morphea","volume":"146","author":"Saxton-Daniels S","year":"2010","journal-title":"Arch Dermatol"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/000155502753600920","article-title":"Two cases of morphea associated with Hashimoto's thyroiditis","volume":"82","author":"Lee HJ","year":"2002","journal-title":"Acta Derm Venereol"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-4632.2004.01973.x","article-title":"Association of vitiligo, morphea and Hashimoto's thyroiditis","volume":"43","author":"Dervis E","year":"2004","journal-title":"Int J Dermatol"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1346-8138.1995.tb03402.x","article-title":"Coexistence of vitiligo and morphea: a case report and review of the literature","volume":"22","author":"Finkelstein E1","year":"1995","journal-title":"J Dermatol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1046\/j.1365-2230.2000.00602.x","article-title":"Morphea presenting shortly after the onset of Schmidt's syndrome","volume":"25","author":"De P","year":"2000","journal-title":"Clin Exp Dermatol"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0190-9622(94)70217-9","article-title":"Clinical characteristics associated with antihistone antibodies in patients with localized scleroderma","volume":"31","author":"Sato S","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000246474","article-title":"Antihistone antibodies in scleroderma","volume":"191","author":"Parodi A","year":"1995","journal-title":"Dermatology"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archderm.1994.01690100053007","article-title":"Serum concentration of procollagen type I carboxyterminal propetide in localized scleroderma","volume":"130","author":"Kikuchi K","year":"1994","journal-title":"Arch Dermatol"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1085-5629(98)80060-6","article-title":"Management of localized scleoderma","volume":"17","author":"Hunzelmann N","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2005.06776.x","article-title":"First case series on the use of imiquimod for morphea","volume":"153","author":"Dytoc M","year":"2005","journal-title":"Br J Dermatol"},{"key":"ref112","first-page":"1281","article-title":"Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis","volume":"22","author":"Clements P","year":"1995","journal-title":"J Rheumatol"},{"key":"ref113","first-page":"650","article-title":"Localized scleroderma severity index and global assessments: a pilot study of outcome instruments","volume":"35","author":"Arkachaisri T","year":"2008","journal-title":"J Rheumatol"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2006.07.004","article-title":"Systemic and localized scleroderma","volume":"24","author":"Chung L","year":"2006","journal-title":"Clin Dermatol"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"231.6","DOI":"10.1016\/j.jaad.2010.05.046","article-title":"Update on morphea: part II. Outcome measures and treatment","volume":"64","author":"Fett N","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref116","first-page":"1213","article-title":"Treatment of morphea or localized scleroderma: review of the literatura","volume":"9","author":"Vilela FA1","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"ref117","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1365-2133.2006.07497.x","article-title":"Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphea) in children","volume":"155","author":"Weibel L","year":"2006","journal-title":"Br J Dermatol"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.30264","article-title":"Methotrexate treatment in juvenile localized scleroderma: a randomized, double-blind, placebocontrolled trial","volume":"63","author":"Zulian F","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","volume":"136","author":"Uziel Y","year":"2000","journal-title":"J Pediatr"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jaad.2010.09.006","article-title":"A systematic review of morphea treatments and therapeutic algorithin","volume":"65","author":"Zwischenberger B","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","article-title":"Topical calcipotriene for morphea\/linear scleroderma","volume":"39","author":"Cunningham BB","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"ref122","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1067\/mjd.2000.108369","article-title":"Double-blind, placebo-controlled study of oral calcitriol for treatment of localized and systemic scleroderma","volume":"43","author":"Hulshof MM","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1525-1470.1999.99016.x","article-title":"Treatment of linear scleroderma with oral 1,25-ddihydroxyvitamin D3 (calcitriol) in seven children","volume":"16","author":"Elst EF","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1346-8138.2000.tb02213.x","article-title":"Scleroderma en Coup de Sabre with Central Nervous System Involvement","volume":"27","author":"Higashi Y","year":"2000","journal-title":"J Dermatol"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00128071-200910030-00004","article-title":"Efficacy of topical tacrolimus 0,1% in active plaque morphea: randomized, double-blind, emoliente-controlled pilot study","volume":"10","author":"Kroft EB","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/09546630802132668","article-title":"Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness","volume":"20","author":"Campione E","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2133.2007.07971.x","article-title":"First case series on the use of calcipotriol-betamethasone dipropionate for morphea","volume":"157","author":"Dytoc MT","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","article-title":"Combined treatment with calcipotriol ointment and low-dose ultravioleta A I phototherapy in childhood morphea","volume":"18","author":"Kreuter A","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/rheumatology\/kep244","article-title":"Sucessful treatment of severe or methotrexate resistant juvenile localized scleroderma with mycophenolate mofetil","volume":"48","author":"Martini G","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(98)70079-9","article-title":"Low-dose methotrexate in the treatment of widespread morphea","volume":"39","author":"Seyger MM","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archderm.141.7.847","article-title":"Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma","volume":"141","author":"Kreuter A","year":"2005","journal-title":"Arch Dermatol"},{"key":"ref132","first-page":"609","article-title":"Treatment of pediatric localized scleroderma with methotrexate","volume":"33","author":"Fitch PG","year":"2006","journal-title":"J Rheumatol"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11845-008-0217-0","article-title":"Juvenile localized scleroderma: a retrospective review of response to systemic treatment","volume":"177","author":"Cox D","year":"2008","journal-title":"Ir J Med Sci"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.1994.01690050133027","article-title":"Treatment of severe forms of localized scleroderma with oral corticosteroids: folow-up study on 17 patients","volume":"130","author":"Joly P","year":"1994","journal-title":"Arch Dermatol"},{"key":"ref135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.2011.10535.x","article-title":"Relapse after systemic treatment in pediatric morphea","volume":"166","author":"Mirsky L","year":"2012","journal-title":"Br J Dermatol"},{"key":"ref136","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1525-1470.2008.00848.x","article-title":"Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl","volume":"26","author":"Perez Crespo M","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1001\/archdermatol.2008.547","article-title":"Extracorporeal photochemotherapy for generalized deep morphea","volume":"145","author":"Neustadter JH","year":"2009","journal-title":"Arch Dermatol"},{"key":"ref138","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1468-3083.2007.02403.x","article-title":"Sucessful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporal photopheresis and mycophenolate mofetil","volume":"22","author":"Schlaak M","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archdermatol.2010.120","article-title":"Treatment of recalcitrant generalized morphea with infliximab","volume":"146","author":"Diab M","year":"2010","journal-title":"Arch Dermatol"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1016\/j.jaad.2010.02.030","article-title":"Imatinib treatment of generalized localized scleroderma (morphea)","volume":"63","author":"Moinzadeh P","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2752(2000)20:4<167::AID-MICR4>3.0.CO;2-D","article-title":"Restoration of facial contour in Romberg's disease and hemifacial microssomia: experience with 118 cases","volume":"20","author":"Inigo F","year":"2000","journal-title":"Microsurgery"},{"key":"ref142","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1590\/S0365-05962012000100007","article-title":"Localized scleroderma: assessment of the therapeutic response to phototherapy","volume":"87","author":"Buense R","year":"2012","journal-title":"An Bras Dermatol"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-0781.2004.00081.x","article-title":"Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis","volume":"20","author":"El-Mofty M","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.1996.03890350014001","article-title":"PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients","volume":"132","author":"Kerscher M","year":"1996","journal-title":"Arch Dermatol"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1365-2230.2008.02890.x","article-title":"Photochemotherapy for localized morphea: effect on clinical and molecular markers","volume":"33","author":"Usmani N","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1365-2133.2007.07866.x","article-title":"Treatment of localized scleroderma depends on the clinical subtype","volume":"156","author":"Kreuter A","year":"2007","journal-title":"Br J Dermatol"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A randomized controlled study of low-dose UVA1, UVA1 medium-dose, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter A","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref148","first-page":"S787","article-title":"Description of the Localized Scleroderma Subgroup of CARRA net Registry","volume":"63","author":"Wu EY","year":"2011","journal-title":"Arthritis Rheum"},{"key":"ref149","first-page":"654","article-title":"Update on the classification and treatment of localized scleroderma","volume":"104","author":"Marsol B","year":"2013","journal-title":"Actas Dermosifiliogr"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v90n1\/0365-0596-abd-90-01-0062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:43Z","timestamp":1747666843000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962015000100062&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":149,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0365-05962015000100062"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20152890","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2]]}}}